×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TRUMY – terumo corp unsp/adr (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TRUMY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/4
09:18 pm
trumy
Terumo Blood and Cell Technologies introduces APAC C> Ecosystem Blueprint [Yahoo! Finance]
Low
Report
Terumo Blood and Cell Technologies introduces APAC C> Ecosystem Blueprint [Yahoo! Finance]
3/4
09:10 pm
trumy
Terumo Blood and Cell Technologies introduces APAC C> Ecosystem Blueprint
Low
Report
Terumo Blood and Cell Technologies introduces APAC C> Ecosystem Blueprint
2/26
06:28 am
trumy
Terumo (TRUMY) was upgraded by Nomura to "hold".
Low
Report
Terumo (TRUMY) was upgraded by Nomura to "hold".
2/19
04:35 am
trumy
Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships
Low
Report
Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships
2/13
08:53 am
trumy
Terumo reports Q3 results [Seeking Alpha]
Medium
Report
Terumo reports Q3 results [Seeking Alpha]
2/13
06:52 am
trumy
Terumo Corporation (TRUMY) Q3 2026 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Terumo Corporation (TRUMY) Q3 2026 Earnings Call Transcript [Seeking Alpha]
1/8
02:42 am
trumy
????????????????:??????????????2026 [CNET News]
Low
Report
????????????????:??????????????2026 [CNET News]
1/6
08:29 am
trumy
Terumo Launches SurTract™ Safety Syringe in the United States, Powered by Roncadelle Operations' SafeR® Passive Safety Technology
Low
Report
Terumo Launches SurTract™ Safety Syringe in the United States, Powered by Roncadelle Operations' SafeR® Passive Safety Technology
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/8
Q1/2020 6/30/2019 EPS 30.150 ZacksConsensus N/A ActVsEst N/A - N/A
4.7%
11/28 TERUMO CORP/ADR (OTCMKTS: TRUMY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 3.1%
1/9 MicroVention Announces FDA Premarket Approval of a New Flow Diverter for the Treatment of Brain Aneurysms 2.3%
8/8 Q1/2020 6/30/2019 EPS 30.150 ZacksConsensus N/A ActVsEst N/A - N/A 2.1%
8/9 Q1/2020 6/30/2019 EPS 30.150 ZacksConsensus N/A ActVsEst N/A - N/A 0.9%
10/30 TERUMO CORP/ADR (OTCMKTS: TRUMY) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 0.6%
11/28 TERUMO CORP/ADR (OTCMKTS: TRUMY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 3.1%
1/9 MicroVention Announces FDA Premarket Approval of a New Flow Diverter for the Treatment of Brain Aneurysms 2.3%
8/8 Q1/2020 6/30/2019 EPS 30.150 ZacksConsensus N/A ActVsEst N/A - N/A 2.1%
8/9 Q1/2020 6/30/2019 EPS 30.150 ZacksConsensus N/A ActVsEst N/A - N/A 0.9%
10/30 TERUMO CORP/ADR (OTCMKTS: TRUMY) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 0.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: